Why the study?
Guidelines do not recommend considering AF pattern for the indication of anticoagulation, prompting assessment of AF pattern and cardiovascular event risk.
Does the pattern of atrial fibrillation affect the risk of cardiovascular events in anticoagulated versus non-anticoagulated patients?
Does the pattern of atrial fibrillation affect the risk of cardiovascular events in anticoagulated versus non-anticoagulated patients?
Atrial fibrillation pattern is prognostic for stroke/systemic embolism and heart failure in non-anticoagulated patients, but this risk difference is neutralized by anticoagulation therapy, supporting current guidelines.
Answers are grounded in this paper and cite their sources.
AF pattern may stratify stroke/HF risk off anticoagulation; leaves open whether it modifies therapy decisions in trials.
AIMS: Guidelines do not recommend to take pattern of atrial fibrillation (AF) into account for the indication of anticoagulation (AC). We assessed AF pattern and the risk of cardiovascular events during 2-years of follow-up. METHODS AND RESULTS: We categorized AF as paroxysmal, persistent, or permanent in 29 181 patients enrolled (2010-15) in the Global Anticoagulant Registry In the FIELD of AF (GARFIELD-AF). We used multivariable Cox regression to assess the risks of stroke/systemic embolism (SE) and death across patterns of AF, and whether this changed with AC on outcomes. Atrial fibrillation pattern was paroxysmal in 14 344 (49.2%), persistent in 8064 (27.6%), and permanent 6773 (23.2%) patients. Median CHA2DS2-VASc, GARFIELD-AF, and HAS-BLED scores assessing the risk of stroke/SE and/or bleeding were similar across AF patterns, but the risk of death, as assessed by the GARFIELD-AF risk calculator, was higher in non-paroxysmal than in paroxysmal AF patterns. During 2-year follow-up, after adjustment, non-paroxysmal AF patterns were associated with significantly higher rates of all-cause death, stroke/SE, and new/worsening congestive heart failure (CHF) than paroxysmal AF in non-anticoagulated patients only. In anticoagulated patients, a significantly higher risk of death but not of stroke/SE and new/worsening CHF persisted in non-paroxysmal compared with paroxysmal AF patterns. CONCLUSION: In non-anticoagulated patients, non-paroxysmal AF patterns were associated with higher risks of stroke/SE, new/worsening HF and death than paroxysmal AF. In anticoagulated patients, the risk of stroke/SE and new/worsening HF was similar across all AF patterns. Thus AF pattern is no longer prognostic for stroke/SE when patients are treated with anticoagulants. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362.
No takes yet. Share an insight, caveat, or question.
Atar et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: